{"entity":{"id":"nct03925662","kind":"trial","name":"Mebendazole as Adjuvant Treatment for Colon Cancer","aka":[],"tldr":"A phase 3 trial of mebendazole in colorectal cancer, run by Sherief Abd-Elsalam, now recruiting.","summary":"Mebendazole as Adjuvant Treatment for Colon Cancer is a phase 3, randomised interventional study registered as NCT03925662 by Sherief Abd-Elsalam, with a registry enrolment figure of 40 participants, started 2019-04-01 and due to reach its primary completion in 2028-12. Interventions recorded: Folfox with avastin; Mebendazole. Conditions listed: Colorectal Cancer. Primary outcome: number of patients with tumour response. Colorectal eligibility wording from the registry: \"* Colorectal cancer stage 4\". Sites: Egypt. No results are recorded here; the registry entry is the source.","status":"recruiting","asOf":"2026-09-24","links":[{"label":"ClinicalTrials.gov NCT03925662","url":"https://clinicaltrials.gov/study/NCT03925662"}],"tags":["ctgov-ingest","colorectal-deep-dive"],"related":[],"cancers":["colon-cancer"],"sections":[],"technologies":[],"targets":[],"drugs":["mebendazole"],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT03925662","phase":"3","setting":"Clinical Study Evaluating Mebendazole as Adjuvant Therapy in Patients With Colorectal Cancer","sponsor":"Sherief Abd-Elsalam","enrolled":40,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct03925662/","neighbours":{"cancer":[{"id":"colon-cancer","kind":"cancer","name":"Colon cancer (adenocarcinoma of the colon)","route":"/cancers/colon-cancer/"}],"drug":[{"id":"mebendazole","kind":"drug","name":"Mebendazole","route":"/drugs/mebendazole/"}],"term":[{"id":"colorectal-trials-open-today","kind":"term","name":"Colorectal cancer trials open today (registry snapshot)","route":"/terms/colorectal-trials-open-today/"}]}}